0.218

1.49% 0.0032

Protagenic Therapeutics Inc (PTIX)

Overview News Price History Financials Discussions Forecast Stock Split

Protagenic Therapeutics Inc stock is traded at $0.218, with a volume of 173.89K. It is up +1.49% in the last 24 hours and down -18.84% over the past month. Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Previous Close:

$0.2148

Open:

$0.2084

24h Volume:

173.89K

Relative Volume:

0.05

Market Cap:

$1.57M

Revenue:

Net Income/Loss:

$-5.00M

P/E Ratio:

-0.1896

EPS:

-1.15

Net Cash Flow:

$-3.85M

1W Performance:

-9.13%

1M Performance:

-18.84%

6M Performance:

-64.44%

1Y Performance:

-86.10%

1-Day Range:

$0.2045

$0.2282

1-Week Range:

$0.2045

$0.2488

52-Week Range:

$0.179

$1.87

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Name

Protagenic Therapeutics Inc

Sector

Healthcare (1154)

Industry

Biotechnology (677)

Phone

(212) 994-8200

Address

149 FIFTH AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

PTIX's Discussions on Twitter

Compare PTIX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PTIX Protagenic Therapeutics Inc	0.218	1.57M	0	-5.00M	-3.85M	-1.15
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Protagenic Therapeutics Inc Stock (PTIX) Latest News

Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025

Apr 24, 2025

Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.28, a 0.69 Surge/Decline - DWinneX

Apr 24, 2025

Apr 22, 2025

PTIX stock touches 52-week low at $0.25 amid sharp annual decline - MSN

Apr 22, 2025

Apr 18, 2025

Protagenic Therapeutics stockholders approve reverse split authority By Investing.com - Investing.com South Africa

Apr 18, 2025

Protagenic Therapeutics stockholders approve reverse split authority - Investing.com Australia

Apr 18, 2025

Apr 08, 2025

What Did We Note About Insider Trading At Protagenic Therapeutics Inc (NASDAQ: PTIX)? - stocksregister.com

Apr 08, 2025

Apr 02, 2025

PTIX stock plunges to 52-week low, hitting $0.23 By Investing.com - Investing.com Australia

Mar 28, 2025

Mar 25, 2025

Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 6.5% – Here’s Why - Defense World

Mar 25, 2025

Mar 04, 2025

BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews

Mar 04, 2025

Feb 25, 2025

PTIX stock plunges to 52-week low, hitting $0.25 By Investing.com - Investing.com Canada

Feb 25, 2025

Feb 24, 2025

Protagenic Therapeutics adjusts stock option prices By Investing.com - Investing.com South Africa

Feb 24, 2025

Protagenic Therapeutics adjusts stock option prices - Investing.com India

Feb 24, 2025

Protagenic Therapeutics Reprices Stock Options at Annual Meeting - TipRanks

Feb 24, 2025

Feb 13, 2025

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - ACCESS Newswire

Feb 13, 2025

Feb 06, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Feb 06, 2025

PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle

Feb 06, 2025

Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex

Feb 06, 2025

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 06, 2025

Feb 05, 2025